166 related articles for article (PubMed ID: 1847382)
1. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.
Head SC; Karmali MA; Lingwood CA
J Biol Chem; 1991 Feb; 266(6):3617-21. PubMed ID: 1847382
[TBL] [Abstract][Full Text] [Related]
2. Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7.
Ito H; Yutsudo T; Hirayama T; Takeda Y
Microb Pathog; 1988 Sep; 5(3):189-95. PubMed ID: 3063913
[TBL] [Abstract][Full Text] [Related]
3. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
4. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
5. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
6. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
[TBL] [Abstract][Full Text] [Related]
7. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
9. Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.
Saito M; Mylvaganum M; Tam P; Novak A; Binnington B; Lingwood C
J Biol Chem; 2012 May; 287(20):16073-87. PubMed ID: 22418442
[TBL] [Abstract][Full Text] [Related]
10. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
11. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
12. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.
Karmali MA; Petric M; Bielaszewska M
J Clin Microbiol; 1999 Feb; 37(2):396-9. PubMed ID: 9889226
[TBL] [Abstract][Full Text] [Related]
15. Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro.
Holle JU; Williams JM; Harper L; Savage CO; Taylor CM
Pediatr Nephrol; 2005 Sep; 20(9):1237-44. PubMed ID: 15947986
[TBL] [Abstract][Full Text] [Related]
16. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
[TBL] [Abstract][Full Text] [Related]
17. Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity.
Yamasaki S; Furutani M; Ito K; Igarashi K; Nishibuchi M; Takeda Y
Microb Pathog; 1991 Jul; 11(1):1-9. PubMed ID: 1795624
[TBL] [Abstract][Full Text] [Related]
18. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
Bitzan M; Klemt M; Steffens R; Müller-Wiefel DE
Infection; 1993; 21(3):140-5. PubMed ID: 8365810
[TBL] [Abstract][Full Text] [Related]
19. Detection and frequency of VT1, VT2 and eaeA genes in Escherichia coli O157 and O157:H7 strains isolated from cattle, cattle carcasses and abattoir environment in Istanbul.
Yilmaz A; Gun H; Ugur M; Turan N; Yilmaz H
Int J Food Microbiol; 2006 Feb; 106(2):213-7. PubMed ID: 16307816
[TBL] [Abstract][Full Text] [Related]
20. Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit.
Ohmura M; Yamasaki S; Kurazono H; Kashiwagi K; Igarashi K; Takeda Y
Microb Pathog; 1993 Sep; 15(3):169-76. PubMed ID: 8271917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
